Lung Cancer
A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination with Docetaxel in Second-Line Treatment of Patients with Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)
Trial ID: 08094
Contact: Kelli S Watkins
Phone: (281)863-2443
Learn More about this trial.
go back | new search